FATE THERAPEUTICS INC — Investor Relations & Filings
Filings indexed
810
across all filing types
Latest filing
2026-05-13
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
FATE
Fate Therapeutics is a clinical-stage biopharmaceutical company developing programmed cellular immunotherapies for cancer and autoimmune disorders. The company utilizes its proprietary induced pluripotent stem cell (iPSC) product platform to create master iPSC lines for the mass production of universal, off-the-shelf cell products. These multiplexed-engineered cell candidates are designed with novel synthetic controls to deliver multiple therapeutic mechanisms. This approach aims to overcome key limitations inherent to other cell therapies, with the goal of making treatments more effective, routine, and accessible for patients with life-threatening diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | |
| 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | |
| DEF 14A - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-04-24 | English | |
| 10-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | |
| 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | |
| 4 Filing | 2026-01-16 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 45589724 | 10-Q - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | ||
| 45589249 | 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | ||
| 36258782 | DEF 14A - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-04-24 | English | ||
| 32891805 | 10-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | ||
| 32891804 | 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | ||
| 29759794 | 4 Filing | 2026-01-16 | English | ||
| 29759647 | 4 Filing | 2026-01-16 | English | ||
| 29759598 | 4 Filing | 2026-01-16 | English | ||
| 29759605 | 4 Filing | 2026-01-12 | English | ||
| 29759513 | 4 Filing | 2026-01-12 | English | ||
|
2025
5 filings
| |||||
| 12211721 | Regulatory Filings 2025 | 2025-12-29 | English | ||
| 12211726 | 10-Q | 2025-11-13 | English | ||
| 12211728 | 8-K | 2025-11-13 | English | ||
| 12211729 | 8-K | 2025-10-27 | English | ||
| 12211730 | 4 | 2025-10-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
FATE THERAPEUTICS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34091/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34091 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34091 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34091 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34091}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FATE THERAPEUTICS INC (id: 34091)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.